Patient-reported outcomes in relapsing forms of MS: Real-world, global treatment experience with teriflunomide from the Teri-PRO study.
Mult Scler Relat Disord
; 17: 107-115, 2017 Oct.
Article
in En
| MEDLINE
| ID: mdl-29055438
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Toluidines
/
Crotonates
/
Multiple Sclerosis, Relapsing-Remitting
/
Patient Reported Outcome Measures
/
Immunologic Factors
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Mult Scler Relat Disord
Year:
2017
Document type:
Article
Country of publication: